These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2729949)

  • 1. Activity of ICI 195,739, a new oral triazole, compared with that of ketoconazole in the therapy of experimental murine blastomycosis.
    Tucker RM; Hanson LH; Brummer E; Stevens DA
    Antimicrob Agents Chemother; 1989 Apr; 33(4):573-5. PubMed ID: 2729949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activities of the modified polyene N-D-ornithyl amphotericin methyl ester and the azoles ICI 153066, Bay n 7133, and Bay l 9139 compared with those of amphotericin B and ketoconazole in the therapy of experimental blastomycosis.
    Lefler E; Brummer E; Perlman AM; Stevens DA
    Antimicrob Agents Chemother; 1985 Mar; 27(3):363-6. PubMed ID: 3994350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activities of the triazole D0870 in vitro and against murine blastomycosis.
    Clemons KV; Hanson LH; Stevens DA
    Antimicrob Agents Chemother; 1993 May; 37(5):1177-9. PubMed ID: 8517710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of murine pulmonary blastomycosis with SCH 39304, a new triazole antifungal agent.
    Sugar AM; Picard M; Noble L
    Antimicrob Agents Chemother; 1990 May; 34(5):896-8. PubMed ID: 2360825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of fluconazole and ketoconazole in experimental murine blastomycosis.
    Stevens DA; Brummer E; McEwen JG; Perlman AM
    Rev Infect Dis; 1990; 12 Suppl 3():S304-6. PubMed ID: 2139516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis.
    Sugar AM; Liu XP
    Antimicrob Agents Chemother; 1996 May; 40(5):1314-6. PubMed ID: 8723494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of itraconazole in blastomycosis in a murine model and comparison with ketoconazole.
    Arathoon EG; Brummer E; Stevens DA
    Mycoses; 1989; 32 Suppl 1():109-12. PubMed ID: 2561182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCH 39304 in the treatment of acute or established murine pulmonary blastomycosis.
    Brummer E; Hanson LH; Stevens DA
    Antimicrob Agents Chemother; 1991 Apr; 35(4):788-90. PubMed ID: 2069391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of the triazole Bay R 3783 in mouse models of coccidioidomycosis, blastomycosis, and histoplasmosis.
    Pappagianis D; Zimmer BL; Theodoropoulos G; Plempel M; Hector RF
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1132-8. PubMed ID: 2393272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy of itraconazole with macrophages in killing Blastomyces dermatitidis.
    Brummer E; Bhagavathula PR; Hanson LH; Stevens DA
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2487-92. PubMed ID: 1336949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative activities of UK-49,858 and amphotericin B against Blastomyces dermatitidis infections in mice.
    Lyman CA; Sugar AM; Diamond RD
    Antimicrob Agents Chemother; 1986 Jan; 29(1):161-2. PubMed ID: 3015001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of murine pulmonary blastomycosis with SCH 51048, a broad-spectrum triazole antifungal agent.
    Sugar AM; Picard M
    Antimicrob Agents Chemother; 1995 Apr; 39(4):996-7. PubMed ID: 7786012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of voriconazole in the treatment of central nervous system blastomycosis.
    Ta M; Flowers SA; Rogers PD
    Ann Pharmacother; 2009 Oct; 43(10):1696-700. PubMed ID: 19724015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of voriconazole in treatment of murine pulmonary blastomycosis.
    Sugar AM; Liu XP
    Antimicrob Agents Chemother; 2001 Feb; 45(2):601-4. PubMed ID: 11158762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of chronic pulmonary blastomycosis with caspofungin.
    Mardini J; Nguyen B; Ghannoum M; Couture C; Lavergne V
    J Med Microbiol; 2011 Dec; 60(Pt 12):1875-1878. PubMed ID: 21852530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of osseous blastomycosis without pulmonary or disseminated disease and review of the literature.
    Day SR; Weiss DB; Hazen KC; Moore CC
    Diagn Microbiol Infect Dis; 2014 Jun; 79(2):242-4. PubMed ID: 24703876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central nervous system blastomycosis clinical characteristics and outcomes.
    Majdick K; Kaye K; Shorman MA
    Med Mycol; 2021 Jan; 59(1):87-92. PubMed ID: 32470976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent central nervous system blastomycosis in an immunocompetent child treated successfully with sequential liposomal amphotericin B and voriconazole.
    Panicker J; Walsh T; Kamani N
    Pediatr Infect Dis J; 2006 Apr; 25(4):377-9. PubMed ID: 16567998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative activities of Bay n7133, ICI 153,066, and ketoconazole in murine cryptococcosis.
    Graybill JR; Kaster SR; Drutz DJ
    Antimicrob Agents Chemother; 1983 Dec; 24(6):829-34. PubMed ID: 6318660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo activity of hamycin against Blastomyces dermatitidis.
    Shadomy S; Robertson GM; Shadomy HJ; Utz JP; Gamble E
    J Bacteriol; 1969 Feb; 97(2):481-7. PubMed ID: 5773006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.